Sickle Cell Disease in Social Security Disability Evaluations (2025)

Chapter: 9 Overarching Conclusions

Previous Chapter: 8 Sickle Cell Disease and Disability Evaluations
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 225
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 226
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 227
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 228
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 229
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 230
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 231
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 232
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 233
Suggested Citation: "9 Overarching Conclusions." National Academies of Sciences, Engineering, and Medicine. 2025. Sickle Cell Disease in Social Security Disability Evaluations. Washington, DC: The National Academies Press. doi: 10.17226/29319.
Page 234
Next Chapter: Appendix A: Public Meeting Agendas
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.